Some of the genes (such as ATM, ERBB3, ESR1 or TP53) are very well known cancer genes altered in breast cancer and therefore were expected, while other genes (such as CBLB and PRPF8) presented driver mutations that had not been reported before. This evidence concerns the gene ATM and breast cancer.